Advanced hepatocellular carcinoma (HCC)
Clinical trials for Advanced hepatocellular carcinoma (HCC) explained in plain language.
Never miss a new study
Get alerted when new Advanced hepatocellular carcinoma (HCC) trials appear
Sign up with your email to follow new studies for Advanced hepatocellular carcinoma (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo aims to tackle advanced liver cancer
Disease control Not yet recruitingThis study tests an experimental drug called WGI-0301 combined with lenvatinib in 80 people with advanced liver cancer who have already tried one treatment. The goal is to see if the combination is safe, tolerable, and shrinks tumors. It is an open-label, non-placebo trial across…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase 1/2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Donor cells join fight against advanced cancers
Disease control Not yet recruitingThis early study tests whether adding donor natural killer (NK) cells to standard maintenance therapy can safely help control advanced lung and colorectal cancers. About 20 adults will receive NK cell infusions alongside their usual drugs. The main goal is to check for side effec…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase 1/2 • Sponsor: BOE Technology Group Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Targeted chemo infusion plus immunotherapy shows promise for tough liver cancer
Disease control Not yet recruitingThis clinical trial is testing a new approach for people with advanced liver cancer whose first treatment stopped working. The study combines a targeted chemotherapy infusion (paclitaxel liposome) delivered directly into the liver artery with systemic drugs like immunotherapy and…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase 1/2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study tracks immune therapy results in advanced liver cancer
Knowledge-focused Not yet recruitingThis study will follow 75 adults with advanced liver cancer who are already receiving immune checkpoint inhibitors as part of their regular care. Researchers will track how long patients live and how long the cancer stays under control. The goal is to better understand the real-w…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Sponsor: Ahmed Karam Helmy • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC